News
 

New Research Published in Journal of Biotechnology Highlights Utility of InVitria’sRecombinant Human Leukemia Inhibitory Factor in Stem Cell Culture

FORT COLLINS, Colo. – January 6, 2014 – InVitria, a division of Ventria Bioscience, today announced publication of new research demonstrating that InVitria’s animal-component–free recombinant human leukemia inhibitory factor (rhLIF) is comparable to traditional sources of recombinant LIF for the maintenance of pluripotent mouse embryonic stem cells (ESC) in culture.

 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
page 1 of 56